This Perth-Based Medicinal Cannabis Company Has Just Launched A Crowdfunding Campaign

Medicann Health
Home >News >This Perth-Based Medicinal Cannabis Company Has Just Launched A Crowdfunding Campaign

We love a good local success story at Perth Is OK!, and if we come across one that everyone can be part of? Even better!

With the legalisation of cannabis once again in the news, the future of the plant in this country has never been more prescient, which is why we’re excited to share news about a homegrown success story doing some incredible work in the medicinal cannabis field.

Medicann Health is a Perth-based company established in 2019 by founder and CEO Matt Shales with the goal of improving quality of life of people in need using reliable, affordable cannabis products.

Medicann Health

It’s since evolved into a company with a diversified portfolio of products and services including their over the counter products through Hemp Brothers and Endoscent, they also have their prescription medicines available through pharmacies plus a nationwide network of medicinal cannabis specialists through Medicann Clinics, which provides both telehealth appointments for patients Australia wide and their newly opened face-to-face clinic in West Perth.

MediCann Health has also been working on a world-first concussion research project with Curtin University, all the while generating over $2.8 million in revenue at an average of 56% growth quarter on quarter.

And this, dear reader, is where you come in, with Medicann Health having just launched a crowdfunding CAMPAIGN with Birchal to help them grow:

You can also learn more about those concussion trials by checking out THIS recent story on Channel 7, along with the recent below segment on Channel 9 about the future of medicinal cannabis in WA:

Head to the Medicann Health Birchal site to learn more about this crowdfunding opportunity, and check out the Medicann Health website for more information.

This article is sponsored by Medicann Health and happily endorsed by us. Please see our Editorial Policy for more info.